Should You Buy Cardinal Health Inc (CAH) Today? Analysis, Price Targets, and 2026 Outlook.
Analysis Updated At
2026/01/28
BUY for a beginner long-term investor with $50k–$100k. CAH is in a confirmed uptrend (bullish moving-average stack), fundamentals are improving (strong FY2026/Q1 growth), and Wall Street sentiment/price targets have moved meaningfully higher. With no proprietary intraday/swing signals today, this is not a “trade of the day,” but it is a solid long-term entry even if you’re unwilling to wait for a perfect pullback.
Technical Analysis
Trend: Bullish. The moving averages are stacked positively (SMA_5 > SMA_20 > SMA_200), which typically indicates a sustained uptrend.
Momentum: Mixed-to-positive. MACD histogram is slightly above zero (0.0227) but contracting—uptrend intact, yet momentum is cooling near-term. RSI(6) at ~52.6 is neutral, suggesting the stock is not overbought and not oversold.
Levels: Current price 210.62 is essentially at the pivot (210.881). Near-term support sits at S1 207.363 (then S2 205.189). Near-term resistance is R1 214.399 (then R2 216.573). Today’s -1.65% pullback keeps price near a reasonable entry zone within an uptrend rather than a breakout-chase.
Intellectia Proprietary Trading Signals
- [AI Stock Picker](module://ai_stock_pick): No signal on given stock today.
- [SwingMax](module://swingmax): No signal on given stock recently.
Analyst Ratings and Price Target Trends
Recent trend: clearly improving/bullish. Since late 2025 through Jan 2026, multiple firms raised price targets and reiterated Buy/Overweight/Outperform views.
Notable changes: Citi upgraded to Buy (PT raised to $244 from $190). Barclays initiated Overweight (PT $243). TD Cowen raised PT to $233. Morgan Stanley raised PT to $224. Several others moved to ~$220+.
Wall Street pros: (1) confidence in core distribution resilience, (2) specialty/MSO buildout and onboarding upside, (3) guidance and execution have been viewed as de-risking results.
Wall Street cons: lingering concerns around parts of the GMPD businesses and the need to sustain margin recovery/discipline.
Wall Street analysts forecast CAH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CAH is 225.18 USD with a low forecast of 209 USD and a high forecast of 244 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Wall Street analysts forecast CAH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CAH is 225.18 USD with a low forecast of 209 USD and a high forecast of 244 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Current: 210.390
Current: 210.390
